Astellas Pharma, Inc. (ALPMF)
Astellas Pharma Market Cap : 27.95B for April 24, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Pfizer Inc. | 153.59B |
| Nxera Pharma Co., Ltd. | 570.12M |
| PeptiDream Inc. | 971.69M |
| Stemcell Holdings, Inc. | 60.00M |
Market Cap Related Metrics
| PE Ratio | 13.01 |
| PS Ratio | 2.034 |
| Price to Book Value | 2.484 |
| Price to Free Cash Flow | 11.15 |
| Price | 15.60 |
| Earnings Yield | 7.68% |
| Operating PE Ratio | 10.36 |
| Normalized PE Ratio | 13.01 |